P/B
—
Mannatech
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
$16.3M
Market Cap • 10/23/2026
1993
(33 years)
Founded
1999
(27 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,2
P/EBITDA
4,4
P/OCF
6,6
P/FCF
10,2
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
16,3M
EV
16,8M
EV/Revenue
0,2
EV/EBITDA
4,5
EV/EBIT
6,3
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Dividend Yield 5Y
1%
Payout
0%
Retained Earnings
-12,1M
Profitability
Gross Margin
76,1%
EBITDA Margin
3,5%
EBIT Margin
2,5%
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0,8%
Capex/D&A
82,7%
Capex/OCF
35%
SBC/OCF
11,6%
% PPE
19,2%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-7,4%
CAGR Op. Income 5Y
-15,5%
CAGR OCF 5Y
-27%
Leverage
N.D./EBITDA
0,2
Debt/Equity
0%
Current Ratio
1,2
Quick Ratio
0,4
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!